Turkish Journal of Medical Sciences
Volume 47

Number 6

Article 31

1-1-2017

The diagnostic accuracy of endobronchial ultrasound-guided
transbronchial needle aspiration (EBUS-TBNA) in mediastinal
tuberculous lymphadenitis
ONUR FEVZİ ERER
SERHAT EROL
CEYDA ANAR
CAN BİÇMEN
ZEKİYE AYDOĞDU

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
ERER, ONUR FEVZİ; EROL, SERHAT; ANAR, CEYDA; BİÇMEN, CAN; AYDOĞDU, ZEKİYE; and ÖZKAN, SERİR
(2017) "The diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration
(EBUS-TBNA) in mediastinal tuberculous lymphadenitis," Turkish Journal of Medical Sciences: Vol. 47: No.
6, Article 31. https://doi.org/10.3906/sag-1606-110
Available at: https://journals.tubitak.gov.tr/medical/vol47/iss6/31

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

The diagnostic accuracy of endobronchial ultrasound-guided transbronchial
needle aspiration (EBUS-TBNA) in mediastinal tuberculous lymphadenitis
Authors
ONUR FEVZİ ERER, SERHAT EROL, CEYDA ANAR, CAN BİÇMEN, ZEKİYE AYDOĞDU, and SERİR ÖZKAN

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol47/iss6/31

Turkish Journal of Medical Sciences

Turk J Med Sci
(2017) 47: 1874-1879
© TÜBİTAK
doi:10.3906/sag-1606-110

http://journals.tubitak.gov.tr/medical/

Research Article

The diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle
aspiration (EBUS-TBNA) in mediastinal tuberculous lymphadenitis
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Background/aim: Mediastinal lymph nodes are the second most commonly affected lymph nodes in tuberculous lymphadenitis. It is
often difficult to diagnose tuberculosis in patients with lymphadenopathy without parenchymal lesions. The aim of this study was to
describe the diagnostic utility of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in patients with
isolated mediastinal tuberculous lymphadenitis (MTLA).
Materials and methods: This study included 527 patients who had undergone EBUS-TBNA between December 2012 and December
2014. Patients with the final diagnosis of MTLA were evaluated. The sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV), and accuracy of EBUS-TBNA were calculated.
Results: The prevalence of MTLA in all patients who had undergone EBUS-TBNA for mediastinal lymphadenopathy of unknown
etiology was 5.2% (28/527). EBUS-TBNA was diagnostic in 21/28 (75%) patients, and the remaining 7 patients required additional
procedures for confirmation of diagnosis. Sensitivity, specificity, PPV, NPV, and accuracy of combined cytopathological and
microbiological examinations of EBUS-TBNA in the diagnosis of MTLA were 87.5%, 98.5%, 91.4%, 98%, and 94.4%, respectively. There
were no major complications.
Conclusion: EBUS-TBNA is a safe and effective procedure for the diagnosis of MTLA. When microbiological and cytopathological
examinations of samples are combined, EBUS-TBNA demonstrates good diagnostic accuracy and NPV for the diagnosis of MTLA.
Key words: Lymphadenitis, tuberculosis, mediastinal diseases, endobronchial ultrasound

1. Introduction
Tuberculous lymphadenitis is the most common form
of extrapulmonary tuberculosis (EPT) (1). The most
commonly affected lymph nodes (LNs) are the cervical,
followed by mediastinal, supraclavicular, and inguinal LNs
(2). In the International Standards for Tuberculosis Care it
is recommended that microbiological confirmation must
be made, and diagnostic materials should be obtained
for microbiological and histopathological evaluation for
diagnosis of EPT (3). While it is relatively easy to obtain
lymph node aspiration or excisional biopsy materials
from the peripheral lymph nodes, like the cervical lymph
node, obtaining material for mediastinal tuberculous
lymphadenitis (MTLA) is difficult (4,5). Diagnosis maybe
difficult in the absence of accompanying parenchymal
involvement; the vast majority of such cases have negative
* Correspondence: drserol@yahoo.com
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sputum smears and cultures. Radiological findings of
an adenopathy do not confirm the diagnosis. Moreover,
fungal infections or malignancy can also produce similar
radiological abnormalities.
Mediastinoscopy has been successfully used for
MTLA diagnosis for many years (6). However, compared
to mediastinoscopy, endobronchial ultrasound-guided
transbronchial needle aspiration (EBUS-TBNA) is
minimally invasive, with lower morbidity and mortality
rates, and can be performed as an outpatient procedure
and under conscious sedation. Therefore, EBUS-TBNA
has become the first-line procedure for evaluation of
mediastinal LNs (7).
In this study, we aimed to describe the diagnostic utility
of EBUS-TBNA in patients with isolated intrathoracic
lymphadenopathy due to tuberculosis.
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2. Materials and methods
2.1. Study design and case selection
We retrospectively evaluated our database for patients who
underwent EBUS between December 2012 and December
2014. Over the study period, a total of 527 patients
underwent EBUS-TBNA for the staging and diagnosis of
primary lung cancer, extrapulmonary malignancy, MTLA,
sarcoidosis, and a variety of clinical indications. Only
patients with a final diagnosis of MTLA were included in
the study.
2.2. The EBUS-TBNA procedure
All EBUS-TBNA procedures were performed by the
same bronchoscopist. The EBUS-TBNA procedure was
performed by an EBUS-guided TBNA bronchoscope
(7.5 MHz, BF-UC160F; Olympus, Tokyo, Japan) under
conscious sedation with intravenous midazolam. An
examination of all mediastinal and hilar lymph node
stations accessible by EBUS was performed prior to the
TBNA procedure. Each target nodal station was punctured
at least three times, and one or more tissue core specimens
were obtained with a dedicated 22-gauge needle (NA201SX-4022; Olympus). The aspirate was then blown onto
a glass slide by pushing air using a 20-mL syringe. All
patients provided informed consent before the endoscopic
procedure. The study was approved by the institutional
ethics committee.
2.3. Cytopathological examination
Some amount of aspirate was smeared onto glass slides,
air-dried, fixed immediately with 95% alcohol, and stained
with hematoxylin and eosin (H&E). The rest of the aspirate
was placed into a mixture of formalin and alcohol in
order to obtain a cell block for histological examination.
A cell block was obtained for all patients. Rapid on-site
cytological examination was not available.
2.4. Mycobacterial cultivation, identification, and
molecular detection
Fine-needle aspiration biopsy specimens were suspended
in 1 mL of Middlebrook 7H9 medium and vortexed.
Mycobacterial cultivation was performed by the MGIT
960 system (BD Biosciences, Sparks, MD, USA) according
to the recommendations of the manufacturer, as described
elsewhere (8), and in Lowenstein–Jensen slants (Salubris
AS, İstanbul, Turkey). An acid-fast smear preparation by
fluorochrome and/or Kinyoun staining was also applied to
each processed specimen. Differentiation of M. tuberculosis
and nontuberculous mycobacteria was performed by
conventional methods (9). Mycobacterial cultures were
obtained in all patients.
Nucleic acid amplification tests (NAATs) were used as
the method of detecting the presence of M. tuberculosis
complex DNA directly from clinical specimens during
the study period. The test was the BD ProbeTec ET

Mycobacterium tuberculosis Complex (DTB) (BD
Biosciences) and it was performed and evaluated according
to the recommendations of the manufacturer.
2.5. Final diagnoses of MTLA
Patients were considered to have a diagnosis of MTLA if
there was high clinical and radiological suspicion with one
or more of the following criteria:
1) At least one positive culture of sputum and/or TBNA
specimens for Mycobacterium tuberculosis;
2) At least one acid-fast bacilli (AFB) test and/or NAAT
positive for sputum and/or TBNA specimens;
3) Pathologic results showing granulomatous
inflammation with necrosis or without necrosis, and
clinicoradiological response to antituberculosis treatment.
The diagnosis of sarcoidosis was made based on the
presence of consistent clinical and radiological presentation,
demonstration of granulomas on EBUS with negative AFB
and no growth of mycobacteria on culture, and clinical and
radiological response after treatment with glucocorticoids
or spontaneous remission. EBUS-TBNA results were
considered malignant when the aspirated material
contained malignant cells. A lymph node was accepted as
anthracotic adenitis if the microscopic examination of a
specimen revealed anthracotic pigments. In the presence
of lymphocytes, macrophages, and immunoblasts and no
presence of malignant cells, granulomatous inflammation,
compact anthracotic pigment, and abundantly epithelia
cells, cases were evaluated by the pathologists under the
microscopic examination of aspiration and histological
specimens; if they remained stable for at least 1 year the
lymph node was accepted as reactive adenitis.
2.6. Statistical analysis
Statistical analyses were performed using SPSS 20 (IBM
Corp., Armonk, NY, USA). Descriptive statistics were
expressed as mean ± standard deviation for continuous
variables and as frequency (percentage) for categorical
variables. The sensitivity and negative predictive value
(NPV) of EBUS-TBNA were calculated.
3. Results
Between December 2012 and December 2014, a total of
527 patients underwent EBUS-TBNA; the final diagnosis
was MTLA in 28 patients (Figure). There were 10 male
and 18 female patients with a mean age of 53.4 ± 15.9
years. Sixty-eight LNs were sampled. Subcarinal (station
7) and right lower paratracheal (station 4R) were the most
sampled LNs (Table 1). All cases were negative for HIV.
Twenty-one (75%) of patients with MTLA were
diagnosed with EBUS-TBNA. In 15 of these patients, at
least one of the NAATs, AFB smears, or cultures of EBUSTBNA samples were positive for M. tuberculosis. PCR was
positive in 4 (14.3%) patients, AFB in 4 (14.3%) patients,
and culture in 13 (46.4%).
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EBUS-TBNA
(n=527)

Diagnosis and staging of
malignancy

Benign diseases
(n=215; 40.1%)

(n=312; 59.2%)

MTLA*
(n=28; 5.3%)

Sarcoidosis
(n=86; 16.3%)

Others
(n=101; 19.2%)

Clinical and radiological
decision
(n=4)
Mediastinoscopy
(n=3)
EBUS TBNA(n=21)
Cytopathology (n=6)
Microbiology (n=13)
Both cytopathology and
microbiology (n=2)

Figure. Diagnostic work-up for patients diagnosed with mediastinal tuberculous lymphadenitis.
Table 1. Characteristics of patients and number and station of
sampled lymph nodes.
Sex
Male
Female

10 (35.7%)
18 (64.3%)

Age, years, mean ± SD

53.4 ± 15.9

Number of sampled lymph nodes
1
2
3

3 (10.7%)
15 (53.6%)
10 (35.7%)

The most sampled lymph node stations
Subcarinal
Right lower paratracheal
Left lower paratracheal
Left interlobar
Right upper paratracheal
Right interlobar
Left hilar

1876

23 (76.7%)
21 (70%)
9 (30%)
7 (28.3%)
4 (13.3%)
3 (10%)
1 (3.3%)

In 6 patients EBUS-TBNA cytopathological
examination revealed granulomatous inflammation with
necrosis. In 2 patients both one of the microbiological
tests was positive for M. tuberculosis and cytopathology
reported necrotizing granulomatous inflammation (Table
2; Figure).
The remaining three patients (10.7%) were diagnosed
by mediastinoscopy and 4 (14.3%) patients received
treatment according to clinical and radiologic decisions
(Figure). These 4 patients were excluded from the statistical
analysis despite good response to antituberculosis therapy.
The sensitivity of microbiological examination of
EBUS-TBNA samples alone for the diagnosis of MTLA
was 62.5% (15/24 cases). The sensitivity of cytopathological
examination alone was 33.3%. Sensitivity, specificity,
positive predictive value (PPV), NPV, and accuracy
of combined cytopathological and microbiological
examinations of EBUS-TBNA in the diagnosis of MTLA
were 87.5%, 98.5%, 91.4%, 98%, and 94.4%, respectively.
There were no major complications.
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Table 2. Microbiological and cytopathological results of MTLA patients.
Sputum

EBUS

EBUS-TBNA histopathology Med

N

EBUS
PCR

AFB

Cx

AFB

Cx

NGI

1

-

-

-

-

-

+
+

2

-

-

+

-

-

3

+

-

-

-

-

GI

A

+

AFB

Cx

Ø

Ø

Ø

Ø

Ø

Ø

4

-

-

-

-

-

+

Ø

Ø

5

-

-

-

-

+

+

Ø

Ø

6

-

-

-

-

-

+

Ø

Ø

7

-

-

-

+

+

+

Ø

Ø

-

+

-

+

+

Ø

Ø

8
a

Ø

-

-

-

-

10

Ø

-

-

-

+

9

11

-

-

-

+

+

12

+

-

-

-

-

+
+

-

-

+

Ø

Ø

Ø

Ø

+

Ø

Ø

+

13

Ø

-

-

-

+

+

Ø

Ø

14

-

-

-

-

-

+

Ø

Ø

15

-

-

-

-

-

Ø

Ø

16

+

-

-

+

+

+
+

Ø

Ø

17a

-

-

-

-

-

+

-

+

18a

-

-

-

-

-

+

-

-

19

Ø

-

-

-

-

+

Ø

Ø

20

-

-

-

-

-

+

Ø

Ø

21

-

-

-

-

+

+

Ø

Ø

22

Ø

-

-

-

+

+

Ø

Ø

23b

-

-

-

-

-

-

+

+

24

-

-

-

-

+

+

Ø

Ø

25

-

-

+

-

+

+

Ø

Ø

26

+

-

-

-

+

+

Ø

Ø

27

-

-

-

-

+

+

Ø

Ø

28

Ø

-

-

-

-

Total

4

1

2

4

13

8

14

+

Ø

Ø

6

0

2

MTLA: Mediastinal tuberculous lymphadenitis. Med: Mediastinoscopy.
AFB: Acid-fast bacilli. Cx: Culture for M. tuberculosis. PCR: Polymerase chain reaction.
Ø: Not applicable. GI: Granulomatous inflammation. NGI: Necrotizing granulomatous inflammation.
A: Results other than G and NG.
a
: Mediastinoscopic sample pathology is NGI.
b
: Mediastinoscopic sample pathology is GI.

4. Discussion
In this study we evaluated the diagnostic accuracy of
EBUS-TBNA in the diagnosis of MTLA.
In our study, AFB positivity was 14.3% and culture
positivity was 46.4% in materials obtained from EBUSTBNA. In published data, AFB detection ranged from

0.8% to 48.5%, while culture positivity ranged from 20% to
62% (10–17). When these results are compared with fineneedle aspiration results for peripheral lymph nodes and
EUS studies for mediastinal lymph nodes, sensitivities and
specificities are similar (2,18–21). As a result, conventional
microbiological methods have low diagnostic sensitivity
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for the diagnosis of MTLA, mostly due to a low burden of
bacilli and insufficient sample amount (22).
In recent years, NAATs, like PCR, are being used
in the diagnosis of EPT. PCR can detect even very few
bacilli and contribute greatly to the diagnosis (5). NAATs
are more sensitive than AFB and faster than cultures. In
published studies, PCR has a sensitivity of 17%–100% and
specificity of 67%–100% in the diagnosis of tuberculous
lymphadenitis (23). For EBUS-TBNA-obtained material
NAAT positivity was between 18.2% and 56.7% (11,15–
17). In a policy update published by the WHO, Xpert
MTB/RIF was proposed as a replacement test for the usual
practice (including conventional microscopy, culture,
or histopathology) for testing specific nonrespiratory
specimens (lymph nodes and other tissues) from patients
with suspected tuberculosis (24).
In our study, the sensitivity and specificity of NAATs
was 14.2% and 99.6%, and the results were similar to
those of other studies (11,15–17). It is remarkable that in
our study only one out of 4 patients with positive EBUSTBNA-obtained AFB and two out of 13 patients with
positive EBUS-TBNA-obtained culture for M. tuberculosis
had positive PCR. These results confirm the low sensitivity
of PCR. In our study there were also two false positive
results. One of these patients had previous antituberculosis
treatment. The other was diagnosed with squamous lung
cancer. PCR can produce a false positive result due to
contamination or inability to distinguish between dead
and live bacilli. This is especially observed with DNA-PCR
and in patients who had previous tuberculous treatment
(25).
Microbiological methods have low sensitivity in
the diagnosis of MTLA. Therefore, cytopathological
examination of EBUS-TBNA samples is important.
Existence of granulomatous inflammation with necrosis,
and multinucleated giant cells in aspiration cytology
and cellblock, are considered diagnostic for MTLA (11).
In cases where only granulomatous inflammation is

observed, differential diagnosis for other possible causes,
like sarcoidosis, must be made.
In our study, the cytopathological evaluation of EBUSTBNA samples revealed necrotizing granulomatous
inflammation in 8 (28.6%) cases and granulomatous
inflammation without necrosis in 14 (50%) cases.
In previous studies, the incidence of necrotizing
granulomatous inflammation varied between 27% and
66.7% (10–16).
When microbiological and cytopathological methods
are used together, the sensitivity of EBUS-TBNA in MTLA
diagnosis increases. In our study, when microbiological
and cytopathological results were evaluated together,
EBUS-TBNA was diagnostic in 21 cases, and the sensitivity
of EBUS-TBNA increased to 87.5%. In previous studies,
this sensitivity varied between 70% and 90% (10–17).
Published studies reveal that the most affected lymph
nodes are right hilar and paratracheal lymph nodes (26–
28). In our study, the most affected lymph nodes were
subcarinal, followed by lower right paratracheal lymph
nodes.
Our study has some limitations. Retrospective design
and lower sample size are two of these limitations. The
last limitation is the ‘other’ 101 patients with benign
conditions. Anthracosis, pneumoconiosis, and reactive
adenitis are coded as ‘other benign’. These patients were
followed for at least 1 year. Though we are confident about
the final diagnosis of most of the patients, there is still a
possibility of misdiagnosis of MTLA as reactive adenitis,
especially if EBUS-TBNA cytology was not reported as
granulomatous inflammation.
In conclusion, EBUS-TBNA is a safe and well tolerated
procedure in the diagnosis of MTLA. Upon suspicion,
both microbiological and cytopathological examinations
of EBUS-TBNA samples should be performed. When
microbiology is combined with cytopathological
examination, EBUS-TBNA demonstrates good diagnostic
accuracy for the diagnosis of MTLA.
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